Clinical Trial Evidence (RCT): CosmeRNA ARI in European Androgenetic Alopecia
A 2025 clinical research article published in Clinical and Experimental Dermatology and Therapies reports the results of a six-month, double-blind, randomized, placebo-controlled trial evaluating CosmeRNA ARI in adults with androgenetic alopecia in Germany.
Read moreabout Clinical Trial Evidence (RCT): CosmeRNA ARI in European Androgenetic Alopecia
EADV Congress 2025 – Hair and Nail Disorders Abstract Book
A clinical research abstract presented at the EADV Congress 2025 reported findings from a randomised, double-blind, placebo-controlled study investigating an androgen-receptor-regulating topical approach in women with female pattern hair loss.
Read moreabout EADV Congress 2025 – Hair and Nail Disorders Abstract Book
Overview of Current and Emerging Therapies in Androgenetic Alopecia
A comprehensive expert review published in EMJ Dermatology (November 2024) discusses the evolving landscape of treatments for androgenetic alopecia, the most common form of hair loss in men and women.
Read moreabout Overview of Current and Emerging Therapies in Androgenetic Alopecia
A peer-reviewed research article published in Scientific Reports (Nature Portfolio, 2022) explored the use of an RNA-based topical approach targeting the androgen receptor in individuals affected by androgenetic alopecia.